AltMountain

Nantahala Capital Management, LLC

New Canaan, CT · CRD 158081
Hedge fund manager

Nantahala Capital Management, LLC is an SEC-registered investment adviser based in New Canaan, CT that reports managing 3 hedge funds on Form ADV. It reports $3.1 billion in regulatory assets under management. Its private funds, of all types, hold $1.3 billion in gross assets. Its disclosed U.S. stock holdings returned an estimated +10.3% 2026 YTD through Jun 30 (S&P 500: +9.5%), based on 13F filings. Over a longer period they returned an estimated +100.7% from Q3 2024 to Q2 2026, compared with +37.2% for the S&P 500, based on 13F filings.

Regulatory assets under management
$3.1 billionForm ADV Item 5.F
Gross assets of private funds
$1.3 billionAll private fund types, Form ADV
Hedge funds managed
33 private funds in total
Employees
14Form ADV Item 5.A
Registration
SEC-registered adviserCRD 158081
Latest Form ADV
09/14/2026Disciplinary disclosures: none reported

Estimated 13F portfolio performance

Estimated by AltMountain, derived from the firm’s public Form 13F filings. Not reported by the firm and not the return of any fund.

Estimated from 13F · 2026 YTD+10.3%Through Q2 2026 · S&P 500 +9.5%
Estimated from 13F · 2 years+100.7%Q3 2024 – Q2 2026
S&P 500+37.2%Same quarters, price only
13F holdings$1.6 billion128 positions, 2026-06-30
$100$150$201Q3 2024Q1 2025Q3 2025Q1 202613F est. $201S&P 500 $137
QuarterEst. 13F returnS&P 500
Q2 2026+16.7%+14.8%
Q1 2026-5.5%-4.6%
Q4 2025+13.2%+2.4%
Q3 2025+25.6%+7.8%
Q2 2025+14.5%+10.4%
Q1 2025-6.1%-4.5%
Q4 2024+5.1%+2.1%
Q3 2024+13.2%+5.4%

Estimate of the firm's disclosed long U.S. stock portfolio from its quarterly 13F filings, holding each quarter-end portfolio to the next quarter-end at prices implied by all 13F filers. It is a price return before dividends and fees, ignores shorts, options, bonds, cash and trading within the quarter, and is not the return of any fund. Disclosures

Manager of this firm? Report your fund’s actual net return, or email hello@altmountain.com to correct or remove this estimate. Removal requests from the firm are honored.

13F holdings as of Sep 30, 2026

The 50 largest of 143 share positions ($1,774,065,159) reported by Nantahala Capital Management, LLC on Form 13F for the quarter ended Sep 30, 2026, filed Nov 13, 2026. Shown as filed with the SEC. Original filing on SEC.gov ↗ The estimated return above runs through Jun 30, 2026; it is updated when the SEC publishes its complete data for the quarter.

Share of the reported 13F portfolio, ten largest positions

  • Bioventus Inc4.93%
  • Bancorp Inc Del3.98%
  • Evolus Inc2.82%
  • Peloton Interactive Inc2.54%
  • Eton Pharmaceuticals Inc2.54%
  • Hilton Grand Vacations Inc2.49%
  • Amneal Pharmaceuticals Inc2.40%
  • LB Pharmaceuticals Inc2.32%
  • Savara Inc2.08%
  • Fossil Group Inc2.04%
StockValue% of 13F portfolioSharesShares vs prior quarter
Bioventus Inc$87,516,6494.93%6,420,884+7.01%
Bancorp Inc Del$70,567,7403.98%1,465,277+18.18%
Evolus Inc$49,957,5202.82%6,244,690+11.47%
Peloton Interactive Inc$45,131,7312.54%9,044,435+77.03%
Eton Pharmaceuticals Inc$45,079,8552.54%875,507-25.55%
Hilton Grand Vacations Inc$44,244,9462.49%1,276,542+23.56%
Amneal Pharmaceuticals Inc$42,611,1852.40%2,115,749-6.74%
LB Pharmaceuticals Inc$41,234,4742.32%1,074,374+2.04%
Savara Inc$36,827,7402.08%7,137,159+2.30%
Fossil Group Inc$36,168,6912.04%5,505,128Unchanged
Ultragenyx Pharmaceutical In$35,159,5741.98%2,339,293New
Avalo Therapeutics Inc$32,841,5821.85%2,142,308+15.04%
Mimedx Group Inc$32,203,2281.82%6,910,564+44.95%
Abeona Therapeutics Inc$28,405,8751.60%5,410,643+5.34%
Establishment Labs Hldgs Inc$28,270,4791.59%440,556+31.18%
Titan Machy Inc$26,255,5541.48%1,137,589+0.40%
Adma Biologics Inc$25,982,4641.46%2,590,475+9.77%
Fox Factory Hldg Corp$25,783,8381.45%1,403,584+7.09%
Distribution Solutions GRP I$25,605,5721.44%733,684+48.34%
Fulcrum Therapeutics Inc$24,328,8021.37%6,575,352+20.10%
Xtant Med Hldgs Inc$24,286,7101.37%68,394,000Unchanged
Gogo Inc$24,111,8031.36%11,214,792+28.94%
Aura Biosciences Inc$23,909,8441.35%3,807,300+29.02%
Regeneron Pharmaceuticals$23,613,2861.33%31,141New
Jack In The Box Inc$22,879,3121.29%1,730,659+0.12%
RMR Group Inc$22,651,1121.28%1,252,827+9.14%
Herbalife LTD$22,406,1111.26%1,847,165+66.54%
Opus Genetics Inc$22,116,5161.25%4,569,528+49.26%
Zevra Therapeutics Inc$21,535,1641.21%1,963,096+9.21%
Anteris Technologies Global$21,443,7001.21%2,759,807-18.43%
Inspire Med SYS Inc$20,324,8381.15%293,034+8.74%
Abivax SA$19,679,7301.11%198,745+48.58%
Agomab Therapeutics NV$19,400,2471.09%1,747,770+11.45%
Ridenow Group Inc$18,901,3381.07%3,436,607+5.00%
Rayonier Advanced Matls Inc$17,821,0551.00%2,236,017+31.71%
Vor Biopharma Inc$17,775,7681.00%931,644+10.25%
Tango Therapeutics Inc$17,643,0430.99%707,136+41.24%
Biocryst Pharmaceuticals Inc$17,503,4710.99%2,101,257+10.52%
Mineralys Therapeutics Inc$17,335,7040.98%689,841-15.92%
Geron Corp$17,064,4460.96%13,873,533+13.48%
Keros Therapeutics Inc$16,986,5810.96%1,490,051+5.65%
Benitec Biopharma Inc$16,775,6700.95%1,677,567+12.71%
Obsidian Therapeutics Inc$16,473,1990.93%1,199,796New
Jefferson Capital Inc$15,752,5820.89%825,607+10.08%
Adc Therapeutics SA$15,342,9450.86%12,576,184+2.03%
Camping World Hldgs Inc$14,947,5820.84%2,977,606+16.72%
Janux Therapeutics Inc$14,814,7320.84%857,334+5.85%
Planet Fitness Master Issuer$14,508,3960.82%343,638+23.17%
Verastem Inc$14,327,7120.81%1,779,840-0.70%
Usana Health Sciences Inc$14,304,2170.81%988,543+22.03%

Changes since Jun 30, 2026

Comparing the share counts in the two quarter-end filings: 32 new positions, 17 sold out, 61 increased, 13 reduced and 37 unchanged.

Number of positions (a count, not dollars)

  • New positions32
  • Increased61
  • Unchanged37
  • Reduced13
  • Sold out17

New positions

StockValueShares
Ultragenyx Pharmaceutical In$35,159,5742,339,293
Regeneron Pharmaceuticals$23,613,28631,141
Obsidian Therapeutics Inc$16,473,1991,199,796
Research Alliance Corp III$11,913,0001,100,000
Attovia Therapeutics Inc$9,618,625561,180
Ishares TR$9,573,03334,449
Service Pptys TR Com New$8,930,9341,386,791
Entera Bio LTD$8,744,1073,004,848
Dyne Therapeutics Inc$6,161,076382,438
Damora Therapeutics Inc Com SHS$5,915,840278,000
Dicks Sporting Goods Inc$5,371,60040,000
Tcgx Acquisition Corp$5,166,505412,990
Inflarx NV$4,849,1062,693,948
Pharvaris N V$4,758,000150,000
Sagimet Biosciences Inc$4,661,690471,831
Fractyl Health Inc$4,060,2827,458,269
Jatt III Acquisition Corp$2,755,000250,000
Cue Biopharma Inc$2,484,78896,049
Viatris Inc$2,356,849133,005
Femasys Inc$1,732,633802,145

Sold out

StockValue at Jun 30, 2026Shares held then
Uniqure NV$20,987,700455,660
Integer Hldgs Corp$10,401,172111,302
Fractyl Health Inc$8,968,05811,289,096
Amylyx Pharmaceuticals Inc$8,740,845486,684
Damora Therapeutics Inc$7,230,780278,000
RH$6,043,28536,686
First Tracks Biotherapeutics$5,030,000250,000
Chime Finl Inc$3,524,997172,119
Rallybio Corp$3,014,752188,422
Entrada Therapeutics Inc$2,212,232300,575
Alx Oncology Hldgs Inc$1,552,500750,000
BRC Inc$1,395,4601,257,171
Vyne Therapeutics Inc$1,301,4002,000,000
Snap Inc$888,000200,000
Spar Group Inc$545,926660,688
Biomx Inc$215,232634,995
Guardforce Ai Co LTD$5,420154,205

Largest increases

StockChange in sharesChangeValue nowShares now
Peloton Interactive Inc+3,935,440+77.03%$45,131,7319,044,435
Bancorp Inc Del+225,390+18.18%$70,567,7401,465,277
Mimedx Group Inc+2,143,012+44.95%$32,203,2286,910,564
Herbalife LTD+738,011+66.54%$22,406,1111,847,165
Hilton Grand Vacations Inc+243,372+23.56%$44,244,9461,276,542
Distribution Solutions GRP I+239,103+48.34%$25,605,572733,684
Opus Genetics Inc+1,508,169+49.26%$22,116,5164,569,528
Establishment Labs Hldgs Inc+104,726+31.18%$28,270,479440,556
Abivax SA+64,986+48.58%$19,679,730198,745
Bioventus Inc+420,605+7.01%$87,516,6496,420,884
Gogo Inc+2,517,061+28.94%$24,111,80311,214,792
Aura Biosciences Inc+856,270+29.02%$23,909,8443,807,300
Tango Therapeutics Inc+206,477+41.24%$17,643,043707,136
Evolus Inc+642,669+11.47%$49,957,5206,244,690
Avalo Therapeutics Inc+280,058+15.04%$32,841,5822,142,308
Rayonier Advanced Matls Inc+538,291+31.71%$17,821,0552,236,017
Fulcrum Therapeutics Inc+1,100,312+20.10%$24,328,8026,575,352
Zai Lab LTD+130,000+65.00%$8,692,200330,000
Planet Fitness Master Issuer+64,638+23.17%$14,508,396343,638
Usana Health Sciences Inc+178,469+22.03%$14,304,217988,543

Largest reductions

StockChange in sharesChangeValue nowShares now
Imax Corp-506,512-76.98%$8,302,036151,497
Eton Pharmaceuticals Inc-300,444-25.55%$45,079,855875,507
Duolingo Inc-43,549-51.92%$5,742,70740,328
Anteris Technologies Global-623,528-18.43%$21,443,7002,759,807
Forrester Resh Inc-350,400-45.90%$4,754,159413,046
Mineralys Therapeutics Inc-130,640-15.92%$17,335,704689,841
Amneal Pharmaceuticals Inc-153,002-6.74%$42,611,1852,115,749
Trisalus Life Sciences Inc-500,000-50.00%$2,155,000500,000
Silence Therapeutics PLC-184,347-13.69%$12,704,8571,162,384
Industrial Logistics Pptys T-235,000-21.15%$6,220,686876,153
Inhibikase Therapeutics Inc-750,000-27.76%$4,011,0781,951,863
Codexis Inc-1,025,744-28.31%$3,611,0382,597,869
Verastem Inc-12,570-0.70%$14,327,7121,779,840

Each list shows up to 20 positions, largest first by dollar amount. Changes compare two quarter-end snapshots, with the earlier share count adjusted for stock splits AltMountain detected. They do not show when, or at what price, anything was bought or sold.

From public Form 13F filings, not verified. Form 13F is filed up to 45 days after the quarter ends, so positions may have changed. It lists only certain long positions in U.S.-listed stocks and exchange-traded funds; options are not shown here, and short positions, most bonds, cash, non-U.S. securities and private investments are not reported at all, so a holding may be one side of a hedge. A filing covers the manager as a whole, not any single fund, and filings contain errors. This is not investment advice or a recommendation to buy or sell any security. Disclosures

Large ownership stakes (Schedule 13D and 13G)

CompanyFilingPercent of classSharesFiledSource
Peloton Interactive, Inc.13G amendment6.17%26,118,235Nov 13, 2026SEC.gov ↗
Grace Therapeutics, Inc.13G amendment7.45%1,654,393Nov 13, 2026SEC.gov ↗
TELA Bio, Inc.13G amendment14.5%6,545,596Nov 13, 2026SEC.gov ↗
Fulcrum Therapeutics, Inc.13G amendment8.62%6,575,352Nov 13, 2026SEC.gov ↗
Tessera Defense & Homeland Security Inc.13G amendment2.72%73,054Nov 13, 2026SEC.gov ↗
Fractyl Health, Inc.13G amendment6.91%938,982Nov 13, 2026SEC.gov ↗
Gogo Inc.13G amendment8.28%11,214,792Nov 13, 2026SEC.gov ↗
Yarrow Bioscience, Inc.13G amendment0.46%39,198Nov 13, 2026SEC.gov ↗
Curis, Inc.13G amendment9.99%258,739Nov 13, 2026SEC.gov ↗
DarioHealth Corp.13G amendment9.99%979,036Nov 13, 2026SEC.gov ↗
Senti Biosciences Holdings, Inc.13G amendment4.1%1,332,000Nov 13, 2026SEC.gov ↗
Usana Health Sciences Inc13G5.35%988,543Nov 13, 2026SEC.gov ↗
AEON Biopharma, Inc.13G9.99%5,048,027Nov 13, 2026SEC.gov ↗
Research Alliance Corp III13G14.1%1,100,000Oct 7, 2026SEC.gov ↗
Camping World Holdings, Inc.13G amendment7.16%4,551,055Aug 14, 2026SEC.gov ↗

A firm files Schedule 13G (passive) or 13D (it may seek to influence the company) when it beneficially owns more than 5% of a class of a public company's shares. Each row is the firm's latest such filing for that company since Nov 14, 2025, exactly as filed, and counts shares held across the firm and its affiliates, not by any single fund. An amendment can report a stake that has fallen below 5%. Holdings may have changed since the filing date. Not verified by AltMountain. Showing the 15 most recent of 68 companies. Source: U.S. Securities and Exchange Commission, EDGAR.

Hedge funds filing Form D (3)

Matched to this firm by the fund names and related persons in each Form D. The list may be incomplete.

Private funds reported on Form ADV (6)

Fund
Gross assets
Minimum
Owners
Adviser
Sma2
Delaware, United StatesHedge fund
Gross assets$963M
MinimumNone set
Owners4
AdviserNantahala Capital Management, LLC
Nantahala Capital Partners Si, LP
Delaware, United StatesHedge fund
Gross assets$389M
MinimumNone set
Owners5
AdviserNantahala Capital Management, LLC
Nantahala Capital Partners Limited Partnership
Massachusetts, United StatesHedge fund
Gross assets$287M
Minimum$1.0M
Owners56
AdviserNantahala Capital Management, LLC
NCP Rfm LP
Delaware, United StatesHedge fund
Gross assets$278M
MinimumNone set
Owners7
AdviserNantahala Capital Management, LLC
NCP Cb LP
Delaware, United StatesHedge fund
Gross assets$89.8M
MinimumNone set
Owners5
AdviserNantahala Capital Management, LLC
Sma3
Delaware, United StatesHedge fund
Gross assets$872K
MinimumNone set
Owners1
AdviserNantahala Capital Management, LLC

As reported in the adviser's Form ADV filed May 29, 2024. Funds also listed from Form D are shown above.

From SEC filings. Firm data comes from the SEC's Form ADV data as of Oct 2, 2026; performance estimates come from Form 13F. AltMountain has not verified this information, and it is not an offer, solicitation or recommendation. Full disclosures⁠​​‌‌‌‌‌‌‌‌​​​​​​​​‌​⁠